https://wikimd.com/index.php?action=history&feed=atom&title=CamicinalCamicinal - Revision history2026-04-06T01:22:24ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.com/index.php?title=Camicinal&diff=5369364&oldid=prevPrab: CSV import2024-03-06T06:29:38Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:Camicinal.svg|thumb|{{PAGENAME}}]]<br>'''Camicinal''' (also known as '''GSK962040''') is a [[pharmaceutical drug]] developed by [[GlaxoSmithKline]] for the treatment of [[gastrointestinal disorders]]. It is a [[motilin receptor agonist]], which means it stimulates the [[motilin receptor]] in the [[gastrointestinal tract]] to increase [[gastric motility]].<br />
<br />
== History ==<br />
<br />
Camicinal was first developed by GlaxoSmithKline, a British multinational pharmaceutical company. The drug was designed to target the motilin receptor, a G-protein coupled receptor that plays a crucial role in the regulation of gastrointestinal motility.<br />
<br />
== Mechanism of Action ==<br />
<br />
Camicinal is a motilin receptor agonist. It works by binding to the motilin receptors in the gastrointestinal tract, stimulating them to increase the movement and contractions of the stomach and intestines. This helps to speed up the passage of food through the stomach, improving digestion and relieving symptoms of gastrointestinal disorders.<br />
<br />
== Clinical Trials ==<br />
<br />
Several [[clinical trials]] have been conducted to evaluate the safety and efficacy of Camicinal. These trials have shown that the drug can significantly improve gastric emptying and reduce symptoms in patients with [[gastroparesis]], a condition characterized by delayed gastric emptying.<br />
<br />
== Side Effects ==<br />
<br />
Like all drugs, Camicinal can cause [[side effects]]. The most common side effects reported in clinical trials include nausea, vomiting, and abdominal pain. However, these side effects are usually mild and temporary.<br />
<br />
== Future Research ==<br />
<br />
Further research is needed to fully understand the long-term effects of Camicinal and its potential uses in other gastrointestinal disorders. There is also interest in exploring its potential use in the treatment of [[diabetic gastroparesis]], a common complication of [[diabetes]].<br />
<br />
[[Category:Pharmaceutical drugs]]<br />
[[Category:Gastrointestinal agents]]<br />
[[Category:GlaxoSmithKline]]<br />
{{pharmacology-stub}}</div>Prab